content is characteristic of infants with chronic lung disease of prematurity/bronchopulmonary dysplasia. Oxygen therapy, reactive oxygen species (ROS), and immature antioxidant defenses are major risk factors in chronic lung disease of prematurity/bronchopulmonary dysplasia, but their interrelationship is unclear. The direct effects of raised PO2 and modulation of ROS were examined on proliferation of cultured fetal human ASM cells. A bell-shaped relationship was found between PO2 and DNA synthesis induced by fetal bovine serum, platelet-derived growth factor, and basic fibroblastic growth factor, with peak responses occurring at 10-kPa PO2. Changes in DNA synthesis by PO2 did not occur in the absence of mitogen. ROS generation, estimated by dichlorodihydrofluorescein oxidation, was increased by mitogens but was unaffected by nonmitogens (bradykinin, histamine). There was an inverse relationship between ROS generation and PO2, and mitogeninduced ROS generation was substantially potentiated as the PO2 fell. H2O2 mimicked the effect of PO2 on fetal bovine serumstimulated proliferation, whereas treatment with antioxidants (GSH, N-acetylcysteine) reduced it. These data demonstrate that increases in PO2 above levels found in utero modulate proliferation of fetal ASM cells but only in the presence of growth factors. They also strongly suggest that, under these conditions, proliferation is mediated in part by generation of ROS.
INFANTS WITH CHRONIC LUNG disease of prematurity/bronchopulmonary dysplasia (CLD-BPD) exhibit airway hyperresponsiveness (AHR), poorly reversible airflow obstruction (27, 46) , and, on examination postmortem, the walls of their airways are thickened. This latter feature is associated with airway wall inflammatory processes and increases in the airway wall smooth muscle (ASM) content (5, 22, 45) . As in adult humans, structural factors, such as airway wall thickness, cellular and matrix composition, and airway caliber, are key elements likely to limit airway function in infants. James et al. (23) and Lambert et al. (28) have suggested several possible mechanisms by which increased airway wall thickness and increased ASM content, in particular, lead to the development of AHR and airflow obstruction in asthma. By analogy, similar structural changes in abnormally developed airways are likely to also be key elements in development of airflow obstruction in infants with CLD-BPD. In direct support of this, Solway and Hershenson (42) have linked AHR to increased ASM mass in a model of CLD-BPD in immature rats.
Alterations in CLD-BPD airway wall architecture are intimately associated with lung injury and altered repair mechanisms. Major injury-related risk factors in the lungs of infants with CLD-BPD include barotrauma, due to forced mechanical ventilation, prolonged oxygen therapy, free-radical or reactive oxygen species (ROS) generation, immature pulmonary antioxidant defense systems, and release of proteolytic enzymes into the milieu of the airway wall by a predominantly neutrophil-led inflammatory response (2, 31, 48) . However, the relationship between lung injury as a result of these risk factors and accelerated ASM growth in infants who develop CLD-BPD is unclear. Evidence from cell culture studies using adult ASM cells suggests that several polypeptide growth factors, proinflammatory cytokines, and other mediators stimulate mitogenesis (see Ref. 19 for review). Of these known ASM mitogens, increased expression of platelet-derived growth factor (PDGF) mRNA and increased production of basic fibroblastic growth factor (bFGF) and insulin-like growth factor-I have been identified in hyperoxic models of CLD-BPD in immature rats (7, 17, 18) . Additionally, barotrauma or stretch and increased oxygen or oxidant stress are also potential stimuli that mediate ASM cell proliferation (35, 39, 41) and may modulate cell growth in the developing lung (24, 38) .
The relationship among oxygen, oxidant stress, and accelerated cellular proliferation of fetal human ASM is, however, unknown. Recent studies have reported that ROS generation paradoxically increases in several cell types as the PO 2 falls (see Ref. 9) . In this study, we, therefore, performed experiments to characterize fetal human tracheal ASM cells in culture and to determine the direct effects of a range of PO 2 (and procedures designed to modulate oxidant stress) on proliferation of these cells. In addition, we have examined the relationship among mitogen stimulation, PO 2 , and ROS generation in these cells. Our results demonstrate the first evidence in vitro that exposure of fetal human ASM to moderate relative hyperoxia (i.e., 10 kPa compared with ϳ5 kPa in utero) stimulates increased cellular proliferation, whereas increasing PO 2 to Ն20 kPa causes a progressive decrease in proliferation. This bell-shaped response to PO 2 was dependent on the presence of a mitogenic stimulus. Our results strongly suggest that the relationship between proliferation and PO 2 is dependent on production of ROS, in that it could be mimicked by application of increasing concentrations of H 2 O 2 and suppressed by antioxidants and that polypeptide growth factors that stimulate fetal tracheal smooth muscle cell proliferation also increased ROS generation. Although consistent with the above, an important additional finding, contrary to the generally understood relationship, was that the rate of ROS generation actually increased as PO 2 fell, and this increase in rate was substantially potentiated in the presence of mitogen.
METHODS
Isolation and culture of fetal human trachealis smooth muscle cells. In accordance with procedures approved by the Ethics Committee of St. Thomas' Hospital and The West Lambeth Health Authority, anonymous fetal human tracheae were provided by The Medical Research Council Tissue Bank (Hammersmith Hospital, London, UK) and transported on ice within 6 h of elective termination of pregnancy in RPMI-1640 media containing penicillin-streptomycin (100 U/ml) mixture (Life Technologies, Paisley, UK). Estimated postconceptional age of the tissue ranged from 12 to 18 wk. On arrival, tracheae were transferred into a dissecting tray containing ice-cold Hanks' balanced salt solution (HBSS). The larynx and adventitia surrounding the trachea were cleared, and the epithelium overlying the trachealis muscle was removed by firm scraping of the luminal surface with a rounded scalpel blade. The trachealis was then removed from its cartilage attachments and placed into a 35-mm-diameter dish containing 1.5 ml of HBSS, 10 mg/ml BSA, collagenase (type II, 1 mg/ml), and elastase (type IV, 15 U/ml). The trachealis strip was then chopped finely into small pieces (ϳ1 mm 3 ) and then incubated at 37°C for 40 min. The above procedure resulted in almost complete disassociation of the tissue into single cells. Initial studies using Trypan blue exclusion showed that at least 90% of the dispersed cells were viable. The cell suspension was centrifuged (200 g for 5 min), and the cell pellet was resuspended in DMEM containing 10% fetal bovine serum (FBS) supplemented with sodium pyruvate (1 mM), L-glutamine (2 mM), nonessential amino acid mixture (1ϫ), gentamicin (50 g/ ml), and amphotericin B (1.5 g/ml). Cells were seeded into a single 12.5-cm 2 tissue culture flask. All cultures were initially kept in a CO2-controlled humidified incubator at 37°C with 20-kPa PO2 and 5-kPa PCO2 (normal incubator conditions). Spent culture medium was replaced with fresh every 72 h. At confluence, the cells were successively subcultivated by first scraping into 25 cm 2 and then into a 75-cm 2 flask. Experiments were performed on cells maintained in culture for up to six passages.
Cell acclimatization and stimulation in variable PO 2 environments. Before carrying out experiments, cells were first "acclimatized" in a PO 2 of 5 kPa, a level approximate to that in the umbilical blood supply in utero (3.3-5.9 kPa) (30) . Near-confluent cells, harvested by treatment with 0.01% trypsin-EDTA, were seeded (5 ϫ 10 4 cells/well) into 24-well plates in DMEM containing 10% FBS. After attachment for 24 h in normal incubator conditions, cells in DMEM containing 0.5% FBS were maintained for 72 h in humidified airtight jars (modified anaerobic "Oxoid" jar, BDH, Poole, UK) that were gassed at 37°C with a O 2-5% CO2-balance N2 mixture to provide a PO 2 of 5 kPa. Cell growth was initiated by replacement of the 0.5% FBS-containing medium with fresh DMEM containing 0.5, 2.5, or 10% FBS. Cell culture plates were then randomly divided into those placed into humidified airtight jars and gassed as above to provide an experimental PO 2 of between 5 and 50 kPa, as appropriate, or those placed directly into the incubator (20-kPa PO 2). Jars were regassed every 48 h when spent media were replaced with fresh. Isobaric conditions were maintained in all of the jars by using a one-way bleed valve. PO2 was monitored with an O2 electrode sealed into the jar and did not change significantly from the set value during the period of the experiment. The PO2 and pH of the medium bathing the cells under the above conditions were also examined in five separate experiments to confirm that cells were actually exposed to the appropriate PO2 and normal pH. Cell-conditioned medium was examined by using a blood-gas analyzer (Corning Instruments). In all cases, the pH was ϳ7.25, and, as expected, the PO2 of the media was not significantly different from that measured by the O2 electrode.
MTT reduction. Proliferation of fetal human ASM cells was determined by mitochondrial-dependent reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) after removal of cells from jars on days 2, 4, 7, and 9 after initiation of growth. All MTT reduction assays were performed at 20-kPa PO2 to obviate any effects of varying PO2 on the assay itself. Cell monolayers were washed twice in 500-l DMEM containing 10% FBS. MTT (100 l of 5 mg/ml in PBS; final concentration 0.8 mg/ml) was then added to each well, and the cells were incubated at 37°C for 6 h before overnight solubilization in a further 500-l SDS (10% in 0.01 M HCl). A sample (150 l) from each duplicate well was then transferred to a 96-well microplate, and the optical density was determined by automated dualwavelength spectrophotometry (Anthos HTII, Salzburg, Austria). The application of this method to human adult ASM cell proliferation has already been described in detail (20) . For direct determinations of cell number, cells were detached for counting by hemocytometry by using a trypsin-EDTA solution (0.01% in PBS).
DNA synthesis by using [ 3 H]thymidine labeling. Cells were harvested by using trypsin-EDTA and seeded (5 ϫ 10 4 cells/ well) in 24-well cluster plates in DMEM containing 10% FBS and grown for 7-9 days in normal incubator conditions. Near-confluent cells were then acclimatized as above in DMEM containing 0.5% FBS for 72 h. Thereafter, cell growth was initiated by replacement of the 0.5% FBS with fresh DMEM containing either FBS (0.5, 2.5, or 10%), or 20 ng/ml of recombinant human PDGF isoforms, or bFGF. Each well was also pulsed with [methyl-
3 H]thymidine (1 Ci/well). Cells were then randomly divided into airtight gas jars in which isobaric atmospheres were maintained with mixtures of 5-kPa CO2 and a range of PO2 (2.5-50 kPa) balanced with N 2. After 24 h, stimulation was stopped by removing the radioactive media, washing with ice-cold PBS, and fixing with ice-cold methanol. Cell monolayers were then exposed to ice-cold 5% trichloroacetic acid, and the acid insoluble fraction was lysed in 0.3 M NaOH. Incorporated radioactivity was determined by liquid scintillation spectrometry. Because only three airtight jars were available, ASM cell DNA synthesis studies were limited to assessing the effects of four different oxygen concentrations in any given experiment but always included cells kept at 10-and 20-kPa PO 2. Measurement of intracellular ROS generation. Subconfluent, growth-arrested cells on glass coverslips kept in normal incubator conditions were washed twice in PBS and loaded with 10 M dichlorodihydrofluorescein diacetate (H 2DCF-DA, Molecular Probes, Leiden, The Netherlands) in PBS containing 0.1% BSA for 30 min at 37°C. Cells on coverslips were washed for a further 10 min in H 2DCF-DA-free PBS to allow deesterification and then placed in an airtight perfusion chamber (Warner Instrument, Hamden, CT) positioned on a Zeiss Axiovert 200 inverted microscope. Cells were illuminated with an excitation wavelength of 490 nm, and successive images were taken by using a Fluar ϫ100 oil immersion objective, Sedat Quad dichroic mirror and emitter (Chroma Technology, Brattleboro, VT), and MetaFluor software (Universal Imaging, Downingtown, PA). To minimize photooxidation of H 2DCF, the amount of incident light was reduced to the minimum necessary by using neutral density filters. Exposure time was 25-50 ms with 10-20 s between successive images. Changes in PO2 were achieved by fast perfusion (5 ml/min) of the cell chamber with a physiological salt solution at 37°C, containing 118 mM NaCl, 24 mM NaHCO3, 1 mM MgSO4, 4 mM KCl, 5.56 mM glucose, 5 mM sodium pyruvate, 0.435 NaH2PO4, and 1.8 mM CaCl2, pH 7.4, and continuously bubbled with gas mixtures of 5-kPa CO2 and a range of PO2 (2.5-50 kPa) balanced with N2.
Morphological and immunocytochemical characterization of fetal human tracheal smooth muscle cells. For localization of smooth muscle contractile proteins, cells were grown to near confluence on glass coverslips in DMEM containing 10% FBS and placed into 0.5% FBS for 48 h. Cell monolayers were rinsed twice in ice-cold Ca 2ϩ -Mg 2ϩ -free PBS and fixed with ice-cold methanol. Cells were permeablized by using Tween 20 (0.01% in PBS), and nonspecific antibody binding was blocked with 1% normal goat serum in PBS. Mouse antihuman monoclonal primary antibodies to smooth muscle ␣-actin (sm-␣-actin) (1:500 dilution in 0.1% BSA in PBS) or smooth muscle myosin heavy chain (sm-MHC) (1:500) were incubated with cells for 1 h at 37°C followed by washing in PBS by a goat anti-mouse FITC-conjugated secondary antibody (1:100 dilution in 0.1% BSA in PBS; 1 h at 37°C). In control experiments, primary and/or secondary antibodies were omitted from the protocol, and cells were incubated in PBS containing concentration-matched, isotype-matched controls.
For studies examining heme oxygenase-1 (HO-1) localization, cells on coverslips were grown in normal incubator conditions to near confluence for 9 days in DMEM containing 10% FBS and then acclimatized for a further 72 h by incubation in DMEM containing 0.5% FBS in humidified airtight jars, as described above. After 72 h, medium was replaced with fresh DMEM containing 0.5 or 10% FBS. For each concentration of FBS, cells were then randomly divided into those placed for 24 h into humidified airtight jars at 10-kPa PO2 and those placed directly into the incubator (20-kPa PO2). HO-1 expression was examined by using a human-reactive rabbit polyclonal primary antibody against rat liver HO-1
(1:200 dilution in 0.1% BSA in PBS for 3 h at 37°C, catalogue #OSA-100, StressGen Biotechnologies, York, UK). Specific anti-HO-1 binding was detected by using a goat anti-mouse FITC-conjugated secondary antibody (1:100 dilution in 0.1% BSA in PBS; 1 h at 37°C). After immunostaining, cells were washed twice in deionized water, mounted in PBS-glycerol (1:9), and viewed with an Olympus BX-50 microscope equipped with reflected ultraviolet light illumination.
Western immunoblot detection of HO-1 expression. Cells in 25-cm 2 flasks, stimulated in exactly the same fashion as in the immunocytochemical studies, were washed once with ice-cold PBS containing protease inhibitors (200 M Na 3VO4, 2 mM phenylmethylsulfonyl fluoride) and then lysed by scraping in ice-cold extraction buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM ␤-glycerolphosphate, 2 mM Na3VO4, 1 g/ml leupeptin, 2 mM phenylmethylsulfonyl fluoride). Samples of total protein extracts (10 g/lane) were separated by SDS-PAGE on 10% acrylamide precast gels (Invitrogen, Paisley, UK) and transferred electrophoretically to nitrocellulose membranes. Blots were blocked in PBS containing Tween 20 (0.05%) and dried nonfat milk (5%) for at least 1 h before incubation with an anti-HO-1 polyclonal antibody (1:2,000, catalogue #OSA-100, StressGen Biotechnologies) for 90 min. HO-1 expression was detected by using a goat anti-mouse IgG horseradish peroxidase-conjugated secondary antibody (1:5,000, Santa Cruz Biotechnology) and visualized by enhanced chemiluminescence (AmershamPharmacia, Amersham, UK). To control for small differences in loading, blots were stripped and reprobed with a mouse anti-␤-actin monoclonal antibody (1:5,000, Sigma Chemical, Poole, UK) and detected with the goat anti-mouse IgG horseradish peroxidase-conjugated secondary antibody (1:5,000).
Data analysis. Data in the text and Figs. 2, 3, 5, 6, and 7 legends are expressed as means Ϯ SE of observations obtained from ASM cells cultured from n fetal donors. IC50 values and extrapolated maximum responses were estimated for individual concentration-response curves by using nonlinear least squares regression (SigmaPlot; SPSS, Chicago, IL) where appropriate. IC 50 values were converted to negative logarithmic values for all statistical analyses, although, for ease of comprehension, IC 50 values are given in the text. Data were compared by using one-way or, when stated, two-way ANOVA followed by a Bonferroni test post hoc (SigmaStat, SPSS). A probability value of Ͻ0.05 was considered significant.
Materials. Recombinant human PDGF isoforms, bFGF, PBS (Ca 2ϩ -Mg 2ϩ free), DMEM, FBS, sodium pyruvate, Lglutamine, nonessential amino acids, amphotericin B and gentamicin, and penicillin-streptomycin were obtained from Invitrogen. EDTA (disodium salt) was obtained from BDH. [methyl-3 H]thymidine was purchased from Amersham-Pharmacia. H2DCF-DA was purchased from Molecular Probes. All gases were of research grade (British Oxygen). All other reagents used in this study, including human reactive, mouse monoclonal primary antibodies against sm-␣-actin (clone no. 1A4) and sm-MHC (clone no. h-SMV) and goat anti-mouse FITC-conjugated IgG secondary antibody, were obtained from Sigma Chemical.
RESULTS

Fetal human ASM cell morphology and contractile protein expression in culture.
Immunocytochemical localization of smooth muscle contractile proteins demonstrated that Ͼ95% of fetal human tracheal smooth muscle cells in primary culture expressed sm-␣-actin ( Fig. 1A) and sm-MHC (Fig. 1B) . Additionally, epithelial cells were not found to be a contaminating feature of any of the cultures examined because staining with a monoclonal antibody to pancytokerratin was not detected (data not shown). At confluence, cultures exhibited a typical "hill-and-valley" pattern (not shown), which is characteristic of cultured tracheal smooth muscle cells but not of fibroblasts (19) and is similar to that described for cultured vascular smooth muscle cells by Campbell and Campbell (8) .
Oxygen modulation of fetal human ASM proliferation is serum dependent. FBS-stimulated proliferation of fetal human ASM cell was assessed by direct hemacytometer counts and by the MTT reduction assay and was both time and concentration dependent (Fig. 2) . While differences in FBS-stimulated proliferation due to varying PO 2 atmospheres were not present at day 2 of stimulation (P Ͼ 0.05 by ANOVA, n ϭ 5), subsequent proliferation induced by 10% FBS in cells kept in an atmosphere of 10-kPa PO 2 was significantly greater at days 4, 7, and 9 compared with similar cells maintained in either 5-or 20-kPa PO 2 , implying a bellshaped relationship between proliferation and PO 2 (P Ͻ 0.01-0.001, n ϭ 5, Fig. 2, A and B) . Similarly, at 10-kPa PO 2 , proliferation induced by 2.5% FBS was also significantly greater on days 4, 7, and 9 compared with cells maintained at 5-or 20-kPa PO 2 (P Ͻ 0.05-0.001, n ϭ 5, Fig. 2C ). However, in the presence of 0.5% FBS, which did not itself stimulate significant proliferation until day 9 (not shown), varying the PO 2 did not induce further proliferation (P Ͼ 0.05 by ANOVA, n ϭ 5, Fig. 2D ). Oxygen modulates polypeptide growth factor-stimulated DNA synthesis in fetal human ASM. To characterize in more detail the apparent bell-shaped relationship between fetal ASM cell proliferation and PO 2 (Fig.  2) , it was necessary to examine the effects of a wider range of isobaric oxygen concentrations (2.5-50 kPa). This necessitated the use of separate pregassed airtight jars for each PO 2 concentration. Because only three airtight jars were available, proliferation was, therefore, determined at a single time point by DNA synthesis-a surrogate marker for cell proliferation. The existence of a bell-shaped relationship for DNA synthesis and environmental PO 2 was confirmed in cells stimulated with either 10 or 2.5% FBS but was not present in cells stimulated with 0.5% FBS (Fig.  3A) . Isobaric PO 2 levels from 2.5 to 10 kPa caused a concentration-dependent increase in the sensitivity of fetal ASM cells to both 2.5 and 10% FBS with maximum DNA synthesis occurring at 10-kPa PO 2 (Fig. 3A) . The peak response at 10-kPa PO 2 was significantly different (P Ͻ 0.001, n ϭ 4-8) compared with that induced by either FBS concentration in 20-kPa PO 2 (normal incubator conditions). At 12-kPa PO 2 , FBSstimulated DNA synthesis was less than at 10 kPa but remained significantly elevated (P Ͻ 0.001, n ϭ 4-8) compared with DNA synthesis at 20-kPa PO 2 . Consistent with data presented in Fig. 2 , PO 2 did not affect baseline DNA synthesis (P Ͼ 0.05 by ANOVA, n ϭ 4-8) when FBS was present at only 0.5%.
The observed bell-shaped relationship for DNA synthesis and environmental PO 2 was maintained in cells stimulated with 20 ng/ml of PDGF isoforms or bFGF (Fig. 3B) . Changes in PO 2 levels altered the sensitivity of fetal ASM cells to PDGF-AA, -BB, and -AB and to bFGF, and this effect was again maximal when the PO 2 was 10 kPa (P Ͻ 0.001, n ϭ 4-8). Exclusion of Trypan blue from fetal ASM cells was examined in each of the PO 2 environments. However, significant differences in cell viability were not found in any of cultures kept at 5-, 10-, or 20-kPa PO 2 at any of the time points (days 2, 4, 7, and 9) examined (P Ͼ 0.05 by 2-way ANOVA, n ϭ 4-8), and the cell viability was always Ͼ98.5%.
Mitogen treatment and reduced PO 2 increase ROS generation. Production of ROS has been reported on growth factor stimulation of both vascular (43) and adult bovine tracheal ASM cells (35) . To examine whether the mitogens, which stimulated increased DNA synthesis in fetal human ASM (Fig. 3B) indirectly via the Fenton reaction and by peroxidases), and by hydroxyl radicals yields the fluorescent product 2Ј,7Ј-dichlorofluorescein (DCF) in direct proportion to ROS generation (9, 26) . In all experiments, a steady increase in baseline DCF emission with time was observed under resting conditions. Application of PDGF-BB (10 ng/ml) induced a marked increase (ϳ6-10-fold) in the rate of increase in DCF fluorescence (Fig. 4) . Similar increases were observed with bFGF (20 ng/ml) and 1% FBS (not shown). In contrast, neither 10 M histamine nor bradykinin (data not shown) had any effect on the rate of H 2 DCF oxidation (Fig. 4 ) and, consistent with reports in adult human ASM (33), did not stimulate fetal human ASM proliferation (n ϭ 3 for both, data not shown).
Mitogen-induced generation of H 2 O 2 may be a key event in the proliferative response (43) . As changes in PO 2 might be expected to modulate ROS generation, we examined the direct effects of changes in PO 2 on H 2 DCF oxidation in human fetal ASM cells. In the absence of mitogens, there was an inverse relationship between PO 2 and rate of H 2 DCF oxidation, such that, at a PO 2 of 1 kPa, the rate of H 2 DCF oxidation was 495 Ϯ 34% of that at 20 kPa (P Ͻ 0.001, 28 experiments from 3 donors; Fig. 5 ). In the presence of the mitogen PDGF-BB (10 ng/ml), however, the rate of PO 2 -dependent ROS generation was substantially potentiated (P Ͻ 0.001; Fig. 5 ). In cells treated with PDGF-BB, rates of H 2 DCF oxidation at PO 2 of Յ1 kPa were too rapid to be properly quantified.
H 2 O 2 treatment increases FBS-stimulated proliferation.
To investigate whether exogenous ROS could mimic the effects of PO 2 , H 2 O 2 , a stronger oxidant than molecular oxygen, was examined on FBS-stimulated fetal human ASM proliferation. Similar to findings with varying PO 2 (Figs. 2 and 3) , a bell-shaped relationship for proliferation and increasing H 2 O 2 concen- tration were observed in cells stimulated for 9 days with 2.5% FBS (Fig. 6) . The maximum extent of proliferation induced by 2.5% FBS occurred in the presence of 1 M H 2 O 2 and was significantly greater (P Ͻ 0.05, n ϭ 4) than that induced by FBS alone. However, as the concentration of H 2 O 2 increased Ͼ1 M, proliferation was progressively inhibited, such that, at Ն100 M, proliferation was significantly below that in the absence of H 2 O 2 (P Ͻ 0.05, n ϭ 4; Fig. 6 ). As would be expected, in four experiments, exogenous H 2 O 2 also increased the rate of H 2 DCF oxidation in these cells (data not shown).
GSH and N-acetylcysteine inhibit proliferation. To further determine whether the observed ROS generation was an epiphenomenon or had a critical role in promoting fetal human ASM proliferation, the smallmolecule, sulfhydryl-containing antioxidants GSH and N-acetylcysteine (NAC) were examined on FBS-stimulated fetal human ASM proliferation at 10-kPa PO 2 , the optimum oxygen environment for proliferation of these cells (compare Figs. 2 and 3) . Treatment with either GSH or NAC caused a significant decrease in FBSstimulated proliferation (Fig. 7) . IC 50 was 11 Ϯ 2 and 87 Ϯ 16 M, respectively, with GSH being around eightfold more potent (P Ͻ 0.001, n ϭ 4).
Increased oxygen levels regulate HO-1 expression in proliferating cells. HO-1 expression has previously been used as a marker of oxidant stress (12, 34) . HO-1 expression was, therefore, examined by Western immunoblot in whole lysates of proliferating and nonproliferating cells maintained for 24 h at 10-kPa PO 2 , when maximal proliferation occurred (Figs. 2 and 3 ) or at 20-kPa PO 2 (normal incubator conditions). Detectable levels of HO-1 expression were identified in nonproliferating cells (0.5% FBS) but were found to be unaffected by PO 2 . In contrast, HO-1 levels in proliferating cells (10% FBS) were increased compared with nonproliferating cells, with the greatest expression occurring in cells cultured at 20-kPa PO 2 (Fig. 8A) .
Intense cytosolic staining for HO-1 was detected by immunocytochemistry in 10% FBS-stimulated proliferating cells cultured at 10-kPa PO 2 . In nonproliferating cells, cultured in 0.5% FBS at 10-kPa PO 2 , HO-1 staining was less intense and localized predominantly to the nuclear and perinuclear region with little or no staining detected in the cytoplasm (Fig. 8, B and C) . Similar differences in HO-1 localization in proliferating and nonproliferating cells were found in cultures maintained at 20-kPa PO 2 (data not shown).
DISCUSSION
This is the first study to report proliferative changes in ASM cells cultured from fetal human lung tissue. The cells used in our study fulfilled the accepted morphological and biochemical criteria for identification of smooth muscle cells in primary culture, including uniform expression of sm-␣-actin and sm-MHC, as well as development of a contoured hill-and-valley appearance at confluence (8, 19) . Negative pancytokeratin staining indicated that airway epithelial cells did not contaminate the cultures. The major finding of this study is that changes in PO 2 modulate the sensitivity of fetal human ASM cells to mitogens, and our results strongly imply that ROS generation is a key signaling component for this response. In particular, treatment with the ASM mitogens PDGF-BB, bFGF, and FBS (but not the nonmitogens bradykinin or histamine) increased intracellular ROS generation, as estimated by H 2 DCF oxidation, and this effect was potentiated at low PO 2 . Moreover, exogenous H 2 O 2 , one of the main ROS detected by H 2 DCF oxidation, mimicked the effect of oxygen, and proliferation induced by FBS at 10-kPa PO 2 was inhibited by small-molecule thiol-containing antioxidants (GSH and NAC).
A consequence of preterm birth is a premature marked rise in systemic arterial PO 2 above that normally found in utero. The association between changes in the fetal environment brought about by preterm delivery and CLD-BPD has led to suggestions that physicochemical factors could influence ASM cell proliferation in the fetal lung. To test this hypothesis, experiments were designed to investigate the effects of varying oxygen environments and ROS generation on mitogen-stimulated fetal ASM cell DNA synthesis and proliferation. To better reflect the relatively "normoxic" environment in utero for fetal tissues, where the arterial PO 2 is much lower (ϳ3.3-5.9 kPa) (30), cultured fetal human ASM cells were initially acclimatized to a baseline PO 2 of 5 kPa over 72 h before mitogen stimulation or exposure to higher oxygen-containing environments. Thus exposure of these acclimatized fetal ASM cells to higher PO 2 levels was used to model the conditions of relative hyperoxia occurring at birth and with oxygen therapy.
Using this study design, we found that a bell-shaped relationship existed between mitogen-stimulated (FBS; PDGF-AA, -BB, and -AB; and bFGF) ASM cell prolif- 7 . Inhibition of FBS-stimulated fetal human ASM cell proliferation by the small-molecule, sulfhydryl-containing antioxidants GSH and N-acetylcysteine (NAC). Subconfluent cells were stimulated with 2.5% FBS at 10-kPa PO2 in the absence (E) or presence of increasing concentrations of GSH (F) or NAC (s). Proliferation was assessed at day 9 by using the MTT reduction assay, described in METHODS. Values are means Ϯ SE of duplicate values from independent experiments using cells cultured from 4 different donors, cell passages 2-5. Note, where error bars are not shown, the degree of error fell within the symbols. § P Ͼ 0.05, *** P Ͻ 0.001 compared with proliferation in the absence of antioxidant. eration and PO 2 . A twofold increase in baseline PO 2 from 5 to 10 kPa enhanced mitogen-stimulated proliferation of fetal ASM cells, and peak proliferation was observed at 10 kPa. In contrast, a twofold reduction in baseline PO 2 to 2.5 kPa inhibited mitogen-stimulated fetal human ASM proliferation, and PO 2 Ͼ20 kPa also inhibited proliferation. Importantly, in the absence of mitogen, no relationship between PO 2 and ASM cell proliferation was found, emphasizing a requirement for the presence of mitogen before the modulatory effects of oxygen could be manifest. A similar bellshaped relationship between PO 2 and cell proliferation has been reported in human retinal pigment epithelial cells, with a peak rate of proliferation of ϳ8-kPa PO 2 (4) . This and the present study indicate that human cell proliferation is modulated by PO 2 within the physiological range. Moreover, the "optimal" PO 2 for fetal ASM cell proliferation in vitro is above (i.e., relatively hyperoxic) that found in the fetal environment in utero (ϳ3.3-5.9 kPa) (30). We did not observe differences in cell viability at any of the PO 2 levels examined, suggesting that differences in the extent of proliferation at these PO 2 were not the result of oxygen-induced cell death. Indeed, studies in adult bovine ASM (39) and in airway epithelial cells (32) have demonstrated that high levels of oxygen are not toxic but induce cell cycle arrest by increased expression of cell cycle-dependent protein kinase inhibitors such as p53 and p21 WAF1/CIP1 . These effects were associated with exposure to very high oxygen fractions (Ͼ50-95%) that are outside the physiological range and exceed 50 kPa, the maximum concentration investigated in the present study. Indeed, it should be noted that not only severe hyperoxia (32, 39) but also hypoxia [ϳ1.5 kPa (10)] can increase expression of p53 and p21 WAF1/CIP1 . The mechanism underlying the relationship between PO 2 and accelerated mitogen-stimulated fetal ASM cell proliferation is unknown, although there has been considerable interest in the role of ROS, particularly superoxide, H 2 O 2 , and hydroxyl radicals (24) . Accumulating evidence suggests that ROS are not only injurious by-products of cellular metabolism but, along with the overall oxidant status of a cell, are also essential participants in intracellular signaling and the regulation of mitogenic responsiveness and transcription (6, 9, 12, 37, 43) . H 2 O 2 has been shown to be transiently generated during the signal transduction cascade initiated by polypeptide growth factors such as PDGFs and was required for PDGF-induced tyrosine phosphorylation, mitogen-activated protein (MAP) kinase activation, DNA synthesis, and chemotaxis (43). Page et al. (35) reported increased intracellular ROS generation by PDGF in H 2 DCF-loaded adult bovine ASM cells. Here we report similar findings in fetal human ASM cells, not only with the B-chain homodimer of PDGF, but also with bFGF and FBS. Additionally, we demonstrate that nonmitogens such as bradykinin and histamine do not increase ROS generation, supporting a relationship in these cells between proliferation and ROS generation. This contrasts with other reports from vascular endothelial cells (40, 44) and human keratinocytes (16) , in which bradykinin has been implicated in ROS generation.
Although there is increasing acceptance that ROS generation is an important component in mitogen signaling cascades, controversy exists regarding the effect of PO 2 on ROS generation. Intuitively, one might expect ROS to be increased in hyperoxia, as the substrate, molecular oxygen, is in greater supply. Indeed, in many tissues and cells exposed to excessive levels of oxygen, there is an oxidant stress response, characterized by nuclear and mitochondrial DNA strand damage, as well as protein oxidation and lipid peroxidation (14, 47) . Other features include measures by the cell to limit the oxidant load by increasing the bioavailability or expression of protective antioxidant molecules such as GSH and HO-1 (12, 24, 34) . However, there is now considerable evidence that ROS generation by mitochondria and/or plasma membrane-associated NAD(P)H oxidases are increased by hypoxia and form a key component of hypoxic signaling (9, 26) . Consistent with this, we have shown that ROS generation, as estimated by H 2 DCF oxidation, is rapidly increased in human fetal ASM cells as the PO 2 falls (Fig. 5) . Moreover, there was a synergistic increase in ROS generation when the PO 2 was reduced in the presence of the mitogen PDGF-BB.
Unlike ASM proliferation, however, the relationship between ROS generation and PO 2 was not bell shaped. This could reflect the possibility either that ROS generation is an epiphenomenona, which is independent of proliferation, or that ROS stimulates proliferation at low concentrations but suppresses it at high concentrations. We, therefore, examined the effect of exogenous H 2 O 2 on mitogen-stimulated proliferation and found that H 2 O 2 had a similar capacity to modulate FBSstimulated proliferation of fetal human ASM cells, and, in a fashion, that was reminiscent of the bell-shaped relationship observed for PO 2 (compare Figs. 3 and 6 ). This is consistent with our suggestion that a relatively small increase in ROS stimulates proliferation, whereas higher levels cause suppression, and is also consistent with a recent study showing that superoxide stimulates DNA synthesis in rat fetal lung epithelial cells at low concentrations but inhibits it at high concentrations (24) . Other investigators have found that H 2 O 2 , often in the millimolar range, induces tyrosine phosphorylation and growth factor receptor activation (13, 15 Taken together, our results strongly imply that ROS generation may be a key component of the intracellular signaling pathways that modulate proliferation under these conditions, rather than just a consequence of activation of these pathways. To test this hypothesis further, we examined whether proliferation was inhibited by exogenous small molecule antioxidants. We found that FBS-induced proliferation at 10-kPa PO 2 , the point at which maximum stimulation occurred, was inhibited by both GSH and NAC, suggesting that an increase in ROS is indeed a key signaling component of the enhanced proliferative response. Brar et al. (6) have reported similar findings with NAC in FBS-stimulated primary cultures of adult rat tracheal smooth muscle and suggested that the signaling pathways involved in mitogen-stimulated ASM proliferation are in part dependent on generation of partially reduced oxygen species generated by NAD(P)H oxidoreductase flavoproteins.
There is, therefore, accumulating evidence that low levels of ROS stimulate cellular proliferation, possibly via activation of MAP kinase-dependent pathways. Our own results also strongly suggest that the regulation of growth by ambient oxygen is mediated through modulation of ROS generation. However, we additionally show that both a decrease in PO 2 below 5 kPa, which, in the presence of mitogen, substantially increases ROS generation, and high concentrations of exogenous ROS depress proliferation. Similar data have also recently been presented for the effects of superoxide (24) . It is presently unclear what mechanisms may underlie this depression, although relatively high concentrations of superoxide and H 2 O 2 are known to promote apoptosis (25) . The bell-shaped relationship between proliferation and PO 2 or H 2 O 2 may thus reflect a change in balance between pro-proliferative and proapoptotic processes, although further experiments are required to test this speculation.
The mechanisms underlying the increase in ROS generation during hypoxia and the synergistic potentiation after mitogen stimulation in human fetal ASM cells are presently unclear but could involve either NAD(P)H oxidases or mitochondria. There is presently considerable interest in mitochondrial ROS generation as a key element in hypoxic signaling (9), but our preliminary results using inhibitors of the electron transport chain suggest that, in these cells, mitochondria may only account for a small proportion of ROS under these conditions (unpublished observations). Mitogen-induced rises in intracellular Ca 2ϩ are also unlikely to underlie the synergistic relationship between PO 2 and mitogens, as neither bradykinin nor histamine, which caused marked increases in intracellular Ca 2ϩ in these cells (unpublished observations), had any effect on H 2 DCF oxidation. Further studies are required to determine whether the ROS involved in proliferation originate from mitochondria or an NAD(P)H oxidase and the mechanism underlying the synergistic effect on ROS generation of mitogen stimulation and reduced PO 2 .
Increased expression of HO-1 has been used as an indicator of oxidant stress (11, 12, 34) . HO-1 catalyzes the rate-limiting step in the oxidative conversion of heme to biliverdin, releasing equimolar levels of bilverdin IXa, iron, and carbon monoxide (11) . Of the three known isoforms of heme oxygenase, HO-1 is highly inducible by ROS, and accumulating evidence both in vivo and in vitro suggests that HO-1 plays an important adaptive role in providing cellular and tissue protection against such oxidative stress (11, 34) . Our data showing that HO-1 expression is increased and locates to the cytosol in mitogen-stimulated human fetal ASM cells are generally consistent with this, as we show that ROS generation is substantially increased in the presence of mitogens. However, in proliferating cells, HO-1 expression appeared to be greater in those maintained at 20 than at 10 kPa (Fig. 8) , although the DCF fluorescence data would suggest that the ROS load was greater at 10 kPa than at 20 kPa (Fig. 5) . Indeed, hypoxia has been shown to increase HO-1 expression in several tissue types and cell culture model (29) . At the present time, we can only speculate as to the reasons for this seeming inconsistency, which may reflect differences between acute changes in redox state (DCF fluorescence) and more prolonged redox changes (HO-1), such as those in proliferating cells. It is also very likely that certain species of ROS and free radicals induced by hyperoxia are not detectable using H 2 DCF but are capable of causing cell damage and initiating HO-1 expression. Perhaps consistent with this hypothesis, Kazzaz et al. (25) showed that, whereas hyperoxia causes cell necrosis, superoxide and H 2 O 2 result in apoptosis. More detailed studies are required to elucidate this area.
In summary, we have demonstrated that PO 2 modulates mitogen-stimulated fetal human ASM cell proliferation, and our results strongly implicate generation of intracellular ROS as a key signaling event in this response. These observations in vitro provide a plausible link among oxygen stress, antioxidant status, and growth factors in altered smooth muscle content in the airways of infants with CLD-BPD. Although previous studies have shown that hyperoxia inhibits proliferation of cultured ASM cells from adult rats and adult humans (3, 39) , the present study suggests that the relationship among mitogen-induced fetal human ASM cell proliferation, PO 2 , and ROS is more complex and depends on the level of relative hyperoxia. Fetal human ASM cell proliferation in vitro was maximal at a PO 2 that would be considered supraphysiological for the environment in utero (10 kPa) but close to normal for healthy neonates breathing air. To achieve airway wall geometry consistent with CLD-BPD, the rate of ASM proliferation in neonates receiving assisted ventilation and oxygen therapy may need to be only slightly above the rate of ASM cell proliferation in utero. Our observations could account for such a difference, because developing airways in a growing lung might be expected to be in a milieu of growth factors. Teasing out the complex interrelationship among environmental PO 2 , polypeptide growth factors, ROS generation, and cellular antioxidants may further aid our understanding of ASM accumulation in CLD-BPD. Furthermore, it is important to note that our data lend weight to recent reservations concerning the injudicious use of antioxidants in neonatal disease, as this could disrupt normal development processes in the fetal lung (24) .
